Login Registration
  • english
    • български

Rare Disease Academy

EMA links

  1. Agalsidase beta
  2. Alglucosidase alfa
  3. Avalglucosidase alfa
  4. Berotralstat
  5. Beremagene geperpavec
  6. Burosumab
  7. Caplacizumab
  8. Cannabidiol
  9. Eliglustat
  10. Imiglucerase
  11. Olipudase alfa
  12. Odevixibat
  13. Odevixibat 1
  14. Tolvaptan
  15. Voclosporin
  • Contact us
  • Privacy Notice
  • PV Data Privacy
  • Cookie Policy
  • Terms of Use
  • References
Swixx BioPharma

Copyright © 2026 All rights reserved.

For more information about Swixx Biopharma, please visit www.swixxbiopharma.com.

For any information about products, medical inquiries or adverse event reporting please contact medinfo in your county.

List of contacts is available at https://www.swixxbiopharma.com/en/countries/.

PM-CH-2025-12-8479
Approval date: 28.01.2026.
For HCPs only